These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Retroperitoneal soft tissue sarcomas: prognosis and treatment of primary and recurrent disease in 117 patients. Alldinger I; Yang Q; Pilarsky C; Saeger HD; Knoefel WT; Peiper M Anticancer Res; 2006; 26(2B):1577-81. PubMed ID: 16619574 [TBL] [Abstract][Full Text] [Related]
6. Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays. Cheng H; Dodge J; Mehl E; Liu S; Poulin N; van de Rijn M; Nielsen TO Hum Pathol; 2009 Sep; 40(9):1244-51. PubMed ID: 19368956 [TBL] [Abstract][Full Text] [Related]
7. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance. Massi D; Beltrami G; Capanna R; Franchi A Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563 [TBL] [Abstract][Full Text] [Related]
8. Recent progress in the genomics of soft tissue sarcomas. Conley AP; Trent J; Zhang W Curr Opin Oncol; 2008 Jul; 20(4):395-9. PubMed ID: 18525334 [TBL] [Abstract][Full Text] [Related]
9. A gene expression signature associated with metastatic outcome in human leiomyosarcomas. Lee YF; John M; Falconer A; Edwards S; Clark J; Flohr P; Roe T; Wang R; Shipley J; Grimer RJ; Mangham DC; Thomas JM; Fisher C; Judson I; Cooper CS Cancer Res; 2004 Oct; 64(20):7201-4. PubMed ID: 15492233 [TBL] [Abstract][Full Text] [Related]
10. cDNA microarray-based translational research in soft tissue sarcoma. Lubieniecka JM; Nielsen TO J Surg Oncol; 2005 Dec; 92(4):267-71. PubMed ID: 16299802 [TBL] [Abstract][Full Text] [Related]
11. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases. Sato O; Wada T; Kawai A; Yamaguchi U; Makimoto A; Kokai Y; Yamashita T; Chuman H; Beppu Y; Tani Y; Hasegawa T Cancer; 2005 May; 103(9):1881-90. PubMed ID: 15772959 [TBL] [Abstract][Full Text] [Related]
12. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients. Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813 [TBL] [Abstract][Full Text] [Related]
13. Intratumor versus intertumor heterogeneity in gene expression profiles of soft-tissue sarcomas. Francis P; Fernebro J; Edén P; Laurell A; Rydholm A; Domanski HA; Breslin T; Hegardt C; Borg A; Nilbert M Genes Chromosomes Cancer; 2005 Jul; 43(3):302-8. PubMed ID: 15834945 [TBL] [Abstract][Full Text] [Related]
15. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma. Kang S; Han I; Lee S; Kim W; Kim H Eur J Surg Oncol; 2014 Apr; 40(4):406-11. PubMed ID: 24388741 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of pleomorphic sarcomas (so-called "MFH") in adults. Nascimento AF; Raut CP J Surg Oncol; 2008 Mar; 97(4):330-9. PubMed ID: 18286476 [TBL] [Abstract][Full Text] [Related]
18. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas. Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396 [TBL] [Abstract][Full Text] [Related]
19. Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin? Carneiro A; Francis P; Bendahl PO; Fernebro J; Akerman M; Fletcher C; Rydholm A; Borg A; Nilbert M Lab Invest; 2009 Jun; 89(6):668-75. PubMed ID: 19290004 [TBL] [Abstract][Full Text] [Related]
20. Liposarcoma: new entities and evolving concepts. Dei Tos AP Ann Diagn Pathol; 2000 Aug; 4(4):252-66. PubMed ID: 10982304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]